日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
10/01/2025 | Luye Life Sciences Group Ltd | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | Shorea LBG | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Life Sciences Group Ltd | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical International Co., Ltd. | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Shorea LBG | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Ginkgo (PTC) Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Pharma Holdings Ltd. | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Luye Life Sciences Group Ltd | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Ginkgo (PTC) Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | 刘殿波 | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | 刘殿波 | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 237,861,950(S) | 33.53 6.32 | |
10/01/2025 | Nelumbo Investments Limited | 1313(L) | 37,000,000(L) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
10/01/2025 | UBS Group AG | 1703(L) 1402(S) | +74,000,500(L) +37,000,000(S) | 505,171,643(L) 477,583,143(S) | 13.43 12.70 | |
10/01/2025 | 刘殿波 | 14015(S) | +37,000,000(S) | 1,261,196,703(L) 229,317,950(S) | 33.53 6.10 | |
07/01/2025 | UBS Group AG | 1213(L) 1402(S) | -9,886,500(L) +92,028,711(S) | 443,106,171(L) 449,660,971(S) | 11.78 11.95 | |
03/01/2025 | UBS Group AG | 1305(L) | 68,623,827(L) | 456,292,400(L) 360,935,000(S) | 12.13 9.60 | |
02/01/2025 | UBS Group AG | 1104(L) 1502(S) | +9,105,000(L) -82,994,302(S) | 460,222,164(L) 365,536,264(S) | 12.23 9.72 | |
26/12/2024 | UBS Group AG | 1205(L) | -499,083(L) | 451,269,014(L) 449,603,523(S) | 11.99 11.95 | |
25/12/2024 | UBS Group AG | 1104(L) | +877,500(L) | 451,690,097(L) 450,006,098(S) | 12.01 11.96 | |
24/12/2024 | UBS Group AG | 1205(L) 1502(S) | -9,398,369(L) -9,398,369(S) | 444,198,366(L) 442,514,367(S) | 11.81 11.76 | |
20/12/2024 | UBS Group AG | 1402(S) | +2,693,500(S) | 456,601,225(L) 453,596,218(S) | 12.14 12.06 | |
19/12/2024 | UBS Group AG | 1306(L) | 165,000,000(L) | 452,764,210(L) 447,053,714(S) | 12.04 11.88 | |
18/12/2024 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | 刘殿波 | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | UBS Group AG | 1502(S) | -3,089,369(S) | 460,943,069(L) 448,320,669(S) | 12.25 11.92 | |
18/12/2024 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
18/12/2024 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD2.230(L) | 1,261,196,703(L) 192,317,950(S) | 33.53 5.11 |
13/12/2024 | Kale Asset Holding Ltd | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
13/12/2024 | RRJ Capital Master Fund IV, L.P. | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
13/12/2024 | RRJ Capital IV Ltd | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
13/12/2024 | Ong Tiong Sin | 1316(L) | 105,838,779(L) | 317,516,338(L) | 8.44 | |
12/12/2024 | UBS Group AG | 1402(S) | +3,166,000(S) | 463,296,075(L) 454,292,599(S) | 12.32 12.08 | |
1 2 3 4 5 6 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 06/06/2025 17:59 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |